Since the epidemic in the Americas peaked in the early spring of 2016, a continuous decline in the number of reported Zika virus disease cases has been observed in the majority of countries throughout the Americas and the Caribbean.
Surveillance of infectious diseases in the aftermath of a cyclone is important for the early detection and confirmation of outbreaks. Consideration should be given to setting up a syndromic surveillance alert system if there is a need to reinforce surveillance capacity. Laboratory capacity should be assessed for confirming outbreaks of infectious diseases; if required, a referral mechanism can be established for testing samples of epidemic-prone diseases.
This rapid risk assessment (RRA) addresses the risk of importation of Rift Valley fever (RVF) virus (RVFV) and further spread of the virus within the European Union/European Economic Area (EU/EEA) in relation to the recent increase in cases reported on Mayotte, France.
This report assesses the risk of invasive pulmonary aspergillosis (IPA) among patients with severe influenza in hospital intensive care units in the European Union (EU)/European Economic Area (EEA)
In early October, nine cases of autochthonous dengue were confirmed in the EU, three in Spain and six in France, in three separate outbreaks. These are the first autochthonous dengue cases in continental EU/EEA Member States that were reported this year.
The risks assessed in this document are of the introduction and further spread of monkeypox in the EU/EEA, infection with regards to different settings (e.g. healthcare, community, etc.) and transmission through SoHO.
This update of ECDC’s risk assessment on MERS-CoV was triggered by the detection of a case imported into the EU/EEA from the Kingdom of Saudi Arabia (KSA). In this update, we reassess the risk for EU/EEA residents.
This rapid risk assessment addresses the public health risk associated with the early occurrence of a large number of West Nile virus infections in the EU/EEA and EU neighbouring countries in 2018.
This rapid risk assessment evaluates the risk of transmission and further spread of OXA-48-producing Klebsiella pneumonia e ST392 from travellers having sought medical care in Gran Canaria to healthcare facilities in their country of origin in the EU/EEA.
This update of the risk assessment published on 16 April 2018 was triggered by the unusual size and duration of the current dengue fever outbreak driven by Ae. albopictus, a mosquito vector present in Réunion and widely distributed in the southern part of EU.